Immuneering Corporation (IMRX) Tops Q2 EPS by 10c
Tweet
Share
E-mail
Get Alerts IMRX Hot Sheet
Join SI Premium – FREE
Immuneering Corporation (NASDAQ: IMRX) reported Q2 EPS of ($0.43), $0.10 better than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- RH (RH) Tops Q1 EPS by 12c
- MIND Technology (MIND) Misses Q1 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
